Comorbidity of lipedema and fibromyalgia; effects on disease severity, pain and health-related quality of life

Mehmet Onat Çakıt; Busem Atar; Satı Zülal Ayaz; Ömer Faruk Çelik; Ayşe Güliz Gürdal; Burcu Duyur Çakıt

Makale detayları

Comorbidity of lipedema and fibromyalgia; effects on disease severity, pain and health-related quality of life

Yazarlar:

Mehmet Onat Çakıt | Busem Atar | Satı Zülal Ayaz | Ömer Faruk Çelik | Ayşe Güliz Gürdal | Burcu Duyur Çakıt

Yayıncı:

MediHealth Academy Yayıncılık

Ana Başlıklar:

Fiziksel Tıp ve Rehabilitasyon | Psikiyatri | Sağlık Kurumları Yönetimi

Dergi:

Journal of Medicine and Palliative Care Vol.4 Issue 3, pp.234-240

Belge Tipi:

Makale

Yayın Tarihi:

6/2023

Belge Dili:

İngilizce

Document ID (Org No.):

2001292906

pISSN:

2717-7505

Anahtar kelimeler:

Özet:

 Aims: Both Fibromyalgia FMS and lipedema are characterized by pain in the soft tissue, and they have clinically similar aspects. The Aims of this study were to determine how many of the patients with lipedema met the diagnostic criteria for FMS, the effect of the comorbidity of lipedema and FMS on pain and quality of life, and their relationship with extremity volumes, ultrasonographically measured soft tissue thickness and lipedema disease severity. Methods: 53 women with lipedema and 32 patients with FMS without lipedema were included in the study. Symptom severity scale, widespread pain index, and FMS severity scale were calculated for the diagnosis of FMS. Pain intensity was determined by visual analog scale VAS. The frequency of fibromyalgia was determined in the lipedema group. Lower extremity volumes of both groups were calculated by circumferential measurements and thigh and pretibial soft tissue thicknesses were measured ultrasonographically. Short form-36 quality of life scale was applied to both groups. Results: The mean age of the 53 females with lipedema was 5211.8 years, and for the 32 females with FMS it was 51.910.1 years p0.05. The extremity volumes and soft tissue thicknesses were higher in lipedema group than FMS group p0.001.In lipedema group, 2139.6 patients have fulfilled the FMS criteria. FMS severity scores of Comorbid Lipedema and FMS group were similar with FMS patients p0.199. Bodily pain and VAS were more severe in Comorbid Lipedema and FMS group than lipedema group without FMS and FMS group p0.001. Generally, Short form-36 components were better in lipedema without FMS group than Comorbid FMS and FMS group p0.05 Conclusion: The comorbidity of these two diseases in patients negatively affect their physical and mental functions. Investigation and treatment of comorbid FMS in lipedema patients may contribute to their quality of life and pain.

 Aims: Both Fibromyalgia FMS and lipedema are characterized by pain in the soft tissue, and they have clinically similar aspects. The Aims of this study were to determine how many of the patients with lipedema met the diagnostic criteria for FMS, the effect of the comorbidity of lipedema and FMS on pain and quality of life, and their relationship with extremity volumes, ultrasonographically measured soft tissue thickness and lipedema disease severity. Methods: 53 women with lipedema and 32 patients with FMS without lipedema were included in the study. Symptom severity scale, widespread pain index, and FMS severity scale were calculated for the diagnosis of FMS. Pain intensity was determined by visual analog scale VAS. The frequency of fibromyalgia was determined in the lipedema group. Lower extremity volumes of both groups were calculated by circumferential measurements and thigh and pretibial soft tissue thicknesses were measured ultrasonographically. Short form-36 quality of life scale was applied to both groups. Results: The mean age of the 53 females with lipedema was 5211.8 years, and for the 32 females with FMS it was 51.910.1 years p0.05. The extremity volumes and soft tissue thicknesses were higher in lipedema group than FMS group p0.001.In lipedema group, 2139.6 patients have fulfilled the FMS criteria. FMS severity scores of Comorbid Lipedema and FMS group were similar with FMS patients p0.199. Bodily pain and VAS were more severe in Comorbid Lipedema and FMS group than lipedema group without FMS and FMS group p0.001. Generally, Short form-36 components were better in lipedema without FMS group than Comorbid FMS and FMS group p0.05 Conclusion: The comorbidity of these two diseases in patients negatively affect their physical and mental functions. Investigation and treatment of comorbid FMS in lipedema patients may contribute to their quality of life and pain.

 Aims: Both Fibromyalgia FMS and lipedema are characterized by pain in the soft tissue, and they have clinically similar aspects. The Aims of this study were to determine how many of the patients with lipedema met the diagnostic criteria for FMS, the effect of the comorbidity of lipedema and FMS on pain and quality of life, and their relationship with extremity volumes, ultrasonographically measured soft tissue thickness and lipedema disease severity. Methods: 53 women with lipedema and 32 patients with FMS without lipedema were included in the study. Symptom severity scale, widespread pain index, and FMS severity scale were calculated for the diagnosis of FMS. Pain intensity was determined by visual analog scale VAS. The frequency of fibromyalgia was determined in the lipedema group. Lower extremity volumes of both groups were calculated by circumferential measurements and thigh and pretibial soft tissue thicknesses were measured ultrasonographically. Short form-36 quality of life scale was applied to both groups. Results: The mean age of the 53 females with lipedema was 5211.8 years, and for the 32 females with FMS it was 51.910.1 years p0.05. The extremity volumes and soft tissue thicknesses were higher in lipedema group than FMS group p0.001.In lipedema group, 2139.6 patients have fulfilled the FMS criteria. FMS severity scores of Comorbid Lipedema and FMS group were similar with FMS patients p0.199. Bodily pain and VAS were more severe in Comorbid Lipedema and FMS group than lipedema group without FMS and FMS group p0.001. Generally, Short form-36 components were better in lipedema without FMS group than Comorbid FMS and FMS group p0.05 Conclusion: The comorbidity of these two diseases in patients negatively affect their physical and mental functions. Investigation and treatment of comorbid FMS in lipedema patients may contribute to their quality of life and pain.

 Giriş ve Amaç: Hem Fibromiyalji FMS hem de lipödem yumuşak dokuda ağrı ile karakterizedir ve klinik olarak benzer yönleri vardır. Bu çalışmanın amacı, lipödemli hastaların kaçının FMS tanı kriterlerini karşıladığını, lipödem ve FMS komorbiditesinin ağrı ve yaşam kalitesi üzerindeki etkisini ve ekstremite hacimleri, ultrasonografik olarak ölçülen yumuşak doku kalınlığı ve lipödem hastalık şiddeti ile ilişkisini belirlemektir. Materyal ve Metod: Çalışmaya lipödemli 53 kadın ve lipödemi olmayan 32 FMS hastası dahil edildi. FMS tanısı için semptom şiddet skalası, yaygın ağrı indeksi ve FMS şiddet skalası hesaplandı. Ağrı şiddeti görsel analog skala GAS ile belirlendi. Lipödem grubunda fibromiyalji sıklığı belirlendi. Her iki grubun alt ekstremite hacimleri çevresel ölçümlerle, uyluk ve pretibial yumuşak doku kalınlıkları ise ultrasonografik olarak ölçüldü. Her iki gruba da Kısa Form-36 yaşam kalitesi ölçeği uygulandı. Bulgular: Lipödemli 53 kadının yaş ortalaması 5211.8, FMSli 32 kadının yaş ortalaması 51.910.1 idi p0.05. Ekstremite hacimleri ve yumuşak doku kalınlıkları lipödem grubunda FMS grubuna göre daha yüksekti p0,001. Lipödem grubunda 21 39,6 hasta FMS kriterlerini karşıladı. Komorbid Lipödem ve FMS grubu FMS şiddet skorları FMS hastaları ile benzerdi p0,199. Bedensel ağrı ve VAS, Komorbid Lipödem ve FMS grubunda FMS ve FMS olmayan lipödem grubuna göre daha şiddetliydi p0.001. Genel olarak Kısa Form-36 bileşenleri, FMSsiz lipödem grubunda, Komorbid FMS ve FMS grubuna göre daha iyi bulundu p0.05. Sonuç: Hastalarda bu iki hastalığın birlikte görülmesi hastaların fiziksel ve mental fonksiyonlarını olumsuz etkilemektedir. Lipödem hastalarında FMS komorbiditesinin araştırılması ve tedavisi hastaların yaşam kalitelerine ve ağrılarına katkı sağlayabilir.

Makale detayları

Comorbidity of lipedema and fibromyalgia; effects on disease severity, pain and health-related quality of life

Yazarlar:

Mehmet Onat Çakıt | Busem Atar | Satı Zülal Ayaz | Ömer Faruk Çelik | Ayşe Güliz Gürdal | Burcu Duyur Çakıt

Yayıncı:

MediHealth Academy Yayıncılık

Ana Başlıklar:

Fiziksel Tıp ve Rehabilitasyon | Psikiyatri | Sağlık Kurumları Yönetimi

Dergi:

Journal of Medicine and Palliative Care Vol.4 Issue 3, pp.234-240

Belge Tipi:

Makale

Yayın Tarihi:

6/2023

Belge Dili:

İngilizce

Document ID (Org No.):

2001292906

pISSN:

2717-7505

Lipedema

fibromyalgia

soft tissue thickness

ultrasonographyLipödem

Fibromiyalji

Yumuşak Doku Kalınlığı

Ultrasonografi

Yaşam Kalitesi

Ağrı

Sayı

Makale detayları

Yazarlar: Mehmet Onat Çakıt | Busem Atar | Satı Zülal Ayaz | Ömer Faruk Çelik | Ayşe Güliz Gürdal | Burcu Duyur Çakıt

Yayıncı: MediHealth Academy Yayıncılık

Ana Başlıklar: Fiziksel Tıp ve Rehabilitasyon | Psikiyatri | Sağlık Kurumları Yönetimi

Dergi: Journal of Medicine and Palliative Care Vol.4 Issue 3, pp.234-240

Belge Tipi: Makale

Yayın Tarihi: 6/2023

Belge Dili: İngilizce

Document ID (Org No.): 2001292906

pISSN: 2717-7505

Sayı

Yazarlar:

Mehmet Onat Çakıt | Busem Atar | Satı Zülal Ayaz | Ömer Faruk Çelik | Ayşe Güliz Gürdal | Burcu Duyur Çakıt

Yayıncı:

MediHealth Academy Yayıncılık

Ana Başlıklar:

Fiziksel Tıp ve Rehabilitasyon | Psikiyatri | Sağlık Kurumları Yönetimi

Dergi:

Journal of Medicine and Palliative Care Vol.4 Issue 3, pp.234-240

Belge Tipi:

Makale

Yayın Tarihi:

6/2023

Belge Dili:

İngilizce

Document ID (Org No.):

2001292906

pISSN:

2717-7505